Multiple Sclerosis: Imaging

Magnetic resonance imaging has been used to diagnose and monitor the disease progression in multiple sclerosis. MRI has improved the management of MS patients and provided information on the level of atrophy in the brain and the severity of the disease. Discover the latest research on multiple sclerosis imaging here.

June 23, 2020

Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study

Multiple Sclerosis and Related Disorders
Jan KolcavaYvonne Benešová
June 20, 2020
Preprint
Open Access

Five years functional connectivity reorganization without clinical or cognitive decline in MS

MedRxiv : the Preprint Server for Health Sciences
E. A. HogestolD. Alnaes
July 4, 2020

Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study

Journal of Neurology
Gianna C RiccitelliMaria A Rocca
July 3, 2020

Impact of multiple sclerosis risk loci in postinfectious neurological syndromes

Multiple Sclerosis and Related Disorders
Filippo Martinelli-BoneschiEnrico Marchioni
June 21, 2020

Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort

Multiple Sclerosis and Related Disorders
Correa-Díaz Edgar PatricioGualotuña Pachacama Wilson Alfredo
June 27, 2020

Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study

Multiple Sclerosis and Related Disorders
Hui LuKun Xia
June 23, 2020

Complementary and Alternative Medicine in Radiotherapy: A Comprehensive Review

Topics in Magnetic Resonance Imaging : TMRI
Kai J BormStephanie E Combs
June 27, 2020
Preprint

Fast automatic segmentation of thalamic nuclei from MP2RAGE acquisition at 7 Tesla

ArXiv
Ritobrato DattaManojkumar Saranathan
June 23, 2020

Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre

European Neurology
Rui Duarte ArmindoFilipe Palavra
June 23, 2020

Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory Research
Lisa GlukhovskyJames F Sumowski
July 3, 2020
Open Access

Data Collection in Multiple Sclerosis: The MSDS Approach

Frontiers in Neurology
Tjalf ZiemssenRocco Haase
July 1, 2020

Phosphorus magnetic resonance spectroscopy and fatigue in multiple sclerosis

Journal of Neural Transmission
Paul KauvJérôme Hodel
July 3, 2020

Optic neuropathy: A 15-year retrospective observational study

Multiple Sclerosis and Related Disorders
José Miguel AlvesJoana Guimarães
July 1, 2020

In vivo Characterization of Four 18 F-Labeled S1PR1 Tracers for Neuroinflammation

Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Hui LiuZhude Tu
July 2, 2020
Open Access

Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis

Neuropsychiatric Disease and Treatment
Qingrong OuYangXiaoming Wang

Sign up to follow this feed and discover related papers.

Related Feeds

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-imaging/690d08df-dded-4a18-9a21-bcac5805b09d